The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Non-Therapeutic Biomolecules Market Increase Between 2026 And 2030?
The non-therapeutic biomolecules market has seen substantial growth in recent years. It is anticipated to expand from $33.92 billion in 2025 to $37.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be attributed to several factors, including an escalating demand for research biomolecules, increased utilization in in vitro diagnostics, expansion in pharmaceutical research, advancements in recombinant protein technology, and a rise in collaborations among biotech firms.
The non-therapeutic biomolecules market size is forecast to undergo significant expansion in the coming years. It is expected to reach $56.43 billion in 2030, showing a compound annual growth rate (CAGR) of 10.7%. This expansion over the forecast period is fueled by the widening scope of synthetic biomolecule applications, rising investment in precision medicine, increased adoption in agricultural biotechnology, a growing focus on sustainable and scalable biomolecule production, and innovations in automated biomolecule synthesis platforms. Prominent trends for this period include advanced protein engineering, high-throughput screening technologies, sustainable biomolecule production, cell-free biomolecule synthesis, and customizable biomolecule platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
Which Core Factors Are Supporting The Expansion Of The Non-Therapeutic Biomolecules Market?
A significant rise in research activities and laboratory testing is anticipated to drive the expansion of the non-therapeutic biomolecules market in the coming years. Laboratory testing encompasses medical procedures where bodily samples, such as blood or urine, are examined to diagnose diseases, monitor their progression, and formulate treatment strategies. Conversely, research involves generating novel knowledge or innovatively applying existing knowledge to develop new ideas, theories, and comprehensive understandings. In laboratory tests, non-therapeutic biomolecules serve to quantify the presence or concentration of biomarker molecules indicative of disease, thereby improving the test’s sensitivity and specificity. As an illustration, data from July 2024, released by the National Health Service (NHS), a UK-based hospital and health care provider, indicated that diagnostic activity surpassed pre-pandemic figures in 2023. This included a 21% rise in tests conducted in May 2024 when compared to 2023. Consequently, the escalating volume of research and laboratory testing is fueling the expansion of the non-therapeutic biomolecules market.
How Is The Non-Therapeutic Biomolecules Market Distributed Across Key Segments?
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)
3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support
Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Which Trends Are Guiding The Development Of The Non-Therapeutic Biomolecules Market?
Leading companies in the non-therapeutic biomolecules market are concentrating on developing novel cell separation technology to boost throughput and streamline processes, thereby achieving a competitive edge. This pioneering research-only kit is designed to furnish scientists with an essential solution for biological and laboratory workflow challenges. For example, in May 2023, AcouSort AB, a biotechnology company based in Sweden, unveiled the AcouTrap 3 system. This system integrates the distinctive attributes of acoustofluidics, which merges sound waves with microfluidics, to present an optimized method for isolating cells and extracellular vesicles within a single workflow. The AcouTrap 3 system leverages gentle acoustic trapping technology, enabling scientists to process an increased volume of samples with improved cell viability and reduced loss compared to conventional column- or bead-based techniques, thus enhancing productivity and refining laboratory operations.
Who Are The Companies Shaping The Non-Therapeutic Biomolecules Market Landscape?
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.
Access The Complete Non-Therapeutic Biomolecules Market Report:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Which Region Holds The Largest Share In The Non-Therapeutic Biomolecules Market?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Non-Therapeutic Biomolecules Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2026, By The Business Research Company
Non Therapeutic Biomolecules Market Report 2026
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Peptide Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
Bioengineered Protein Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model